{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22277259",
  "DateCompleted": {
    "Year": "2012",
    "Month": "06",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2012",
        "Month": "01",
        "Day": "23"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ijid.2011.09.026"
    ],
    "Journal": {
      "ISSN": "1878-3511",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "3",
        "PubDate": {
          "Year": "2012",
          "Month": "Mar"
        }
      },
      "Title": "International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",
      "ISOAbbreviation": "Int J Infect Dis"
    },
    "ArticleTitle": "Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002.",
    "Pagination": {
      "StartPage": "e198",
      "EndPage": "e203",
      "MedlinePgn": "e198-203"
    },
    "Abstract": {
      "AbstractText": [
        "Recognizing the uniqueness of secondary dengue virus (DENV)-1/3 dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) cases at an interval of 24 years, we sought to estimate DENV infections as well as the ratios between mild disease and DHF/DSS by DENV infection sequence in Playa District (Havana, Cuba) during the 2001-2002 outbreak of dengue virus type 3 (DENV-3).",
        "A retrospective seroepidemiological study was conducted in 2003 in Playa District. Blood samples were collected from a 1% random sample of residents and were studied for the prevalence of dengue neutralizing antibodies.",
        "DENV-3 was found to have infected 7.2% (95% confidence interval (95% CI) 6.0-8.4%) of susceptible individuals (the entire cohort), the majority of whom experienced silent infections. Virtually every individual who had a secondary infection in the sequence DENV-1 then DENV-3 became ill, with a ratio of severe to mild cases of 1:35 (95% CI 1:67-1:23). Secondary infections in the sequence DENV-2/3 were less pathogenic than DENV-1/3. Mild disease accompanying secondary DENV2/3 occurred at a ratio of 1:4.49 infections (95% CI 1:5.77-1:3.42) secondary infections.",
        "The results obtained highlight the role of the infecting serotype and also the sequence of the viral infection in the clinical outcome of a dengue infection."
      ],
      "CopyrightInformation": "Copyright \u00a9 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Virology, PAHO/WHO Collaborating Center for Study of Dengue and its Vector, Pedro Kouri Tropical Medicine Institute, Autopista Novia del Mediod\u00eda km 6, PO Box 601, Marianao 13, Havana, Cuba. lupe@ipk.sld.cu"
          }
        ],
        "LastName": "Guzman",
        "ForeName": "Maria G",
        "Initials": "MG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Alvarez",
        "ForeName": "Angel",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Vazquez",
        "ForeName": "Susana",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Alvarez",
        "ForeName": "Mayling",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rosario",
        "ForeName": "Delfina",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pelaez",
        "ForeName": "Otto",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cruz",
        "ForeName": "Guillermo",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rodriguez",
        "ForeName": "Rosmari",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pavon",
        "ForeName": "Alequis",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gonzalez",
        "ForeName": "Annia",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Morier",
        "ForeName": "Luis",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ruiz",
        "ForeName": "Dydie",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kouri",
        "ForeName": "Gustavo",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Halstead",
        "ForeName": "Scott B",
        "Initials": "SB"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Canada",
    "MedlineTA": "Int J Infect Dis",
    "NlmUniqueID": "9610933",
    "ISSNLinking": "1201-9712"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Neutralizing"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Antibodies, Neutralizing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "epidemiology",
        "virology"
      ],
      "DescriptorName": "Coinfection"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Cuba"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Dengue Virus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Outbreaks"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epidemiologic Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Serotyping"
    },
    {
      "QualifierName": [
        "epidemiology",
        "virology"
      ],
      "DescriptorName": "Severe Dengue"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}